Results 1 to 10 of about 10,239 (159)

Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis [PDF]

European Journal of Case Reports in Internal Medicine, 2017
Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscle fatiguability and weakness. The pathological characteristics of the disorder include ocular weakness resulting in diplopia and/or ptosis.
Moneeb Sefeldawla Mustafa, Megan Marshal, Emer Ahern, Paul Crowley   +3 more
doaj   +4 more sources

Ocular myasthenia gravis management [PDF]

Frontiers in Neurology
Ocular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Mark J. Kupersmith, Gil I. Wolfe, Henry Kaminski   +2 more
doaj   +2 more sources

Add‐On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real‐World Case Series [PDF]

Brain and Behavior
Introduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional immunotherapies often prove ineffective.
Jing Lin, Yue Li, Mengcui Gui, Bitao Bu, Zhijun Li   +4 more
doaj   +2 more sources

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis

AJP Reports, 2016
Background Myasthenia gravis (MG) is an autoimmune disorder with fluctuating muscle weakness, divided into generalized and localized (ocular) forms.
Naveed Hussain
exaly   +3 more sources

Outcomes of Treatment in Ocular Myasthenia Gravis Based on Minimal Manifestation: A Real-World Retrospective Cohort Study [PDF]

Clinical Ophthalmology
Parinee Kemchoknatee,1 Boonravee Santitamrongvtit,2 Thansit Srisombut3 1Department of Ophthalmology, Rajavithi Hospital, Rangsit University, Bangkok, Thailand; 2Department of Medicine, Phra Nang Klao Hospital, Nonthaburi, Thailand; 3Department of ...
Kemchoknatee P, Santitamrongvtit B, Srisombut T   +2 more
doaj   +2 more sources

Clinical characteristics and outcome predictors of a Chinese childhood-onset myasthenia gravis cohort

Frontiers in Pediatrics, 2022
Myasthenia gravis is an organ-specific autoimmune disease. Currently there is no universal guidelines for childhood-onset myasthenia gravis, therefore, treatment strategies are usually based on the guidelines from adult myasthenia gravis patients.
Lifen Yang, Yulin Tang, Fang He, Ciliu Zhang, Miriam Kessi, Jing Peng, Fei Yin   +6 more
doaj   +1 more source

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab

American Journal of Ophthalmology Case Reports, 2023
Purpose: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3 palsy both subjectively and objectively improving after treatment with eculizumab.
Sara L. Weidmayer, Gary Gallagher
doaj   +1 more source

Concentric Needle Jitter in 97 Myasthenia Gravis Patients

Frontiers in Neurology, 2020
Objectives: To estimate the jitter parameters (single-fiber electromyography) in myasthenia gravis patients mostly by electrical activation in Frontalis, Orbicularis Oculi, and Extensor Digitorum muscles using a concentric needle electrode.Methods ...
João Aris Kouyoumdjian, Gabriel Pina Paiva, Erik Stålberg   +2 more
doaj   +1 more source

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases [PDF]

Frontiers in Immunology
Ruixia Zhu
exaly   +2 more sources

Tolosa-Hunt syndrome with general myasthenia gravis involvement [PDF]

Journal of Integrative Neuroscience, 2020
Tolosa-Hunt syndrome is an uncommon disease that exhibits unilateral periorbital pain or headache, accompanied by cranial nerve palsies. Myasthenia gravis is an acquired immune system disease involving the neuromuscular junction.
Lu Li, Zhe Wang, Ming-Ou Lu
doaj   +1 more source